SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-077678
Filing Date
2022-07-06
Accepted
2022-07-06 16:00:10
Documents
2
Group Members
FFI FUND LTDFYI LTD.LIFANT FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2219525d1_sc13ga.htm SC 13G/A 82475
2 EXHIBIT 99.1 tm2219525d1_ex99-1.htm EX-99.1 8290
  Complete submission text file 0001104659-22-077678.txt   92492
Mailing Address 888 BOYLSTON STREET SUITE 1500 BOSTON MA 02199
Business Address 888 BOYLSTON STREET SUITE 1500 BOSTON MA 02199 617-497-3500
Bracebridge Capital, LLC (Filed by) CIK: 0001426486 (see all company filings)

IRS No.: 043344637 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Subject) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91924 | Film No.: 221068603
SIC: 2836 Biological Products, (No Diagnostic Substances)